| Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer OAW Haabeth, KB Lorvik, C Hammarström, IM Donaldson, G Haraldsen, ... Nature communications 2 (1), 240, 2011 | 337 | 2011 |
| How Do CD4+ T Cells Detect and Eliminate Tumor Cells That Either Lack or Express MHC Class II Molecules? OAW Haabeth, AA Tveita, M Fauskanger, F Schjesvold, KB Lorvik, ... Frontiers in immunology 5, 174, 2014 | 240 | 2014 |
| Adoptive Transfer of Tumor-Specific Th2 Cells Eradicates Tumors by Triggering an In Situ Inflammatory Immune Response KB Lorvik, C Hammarström, M Fauskanger, OAW Haabeth, M Zangani, ... Cancer research 76 (23), 6864-6876, 2016 | 112 | 2016 |
| Interleukin-1 is required for cancer eradication mediated by tumor-specific Th1 cells OAW Haabeth, KB Lorvik, H Yagita, B Bogen, A Corthay Oncoimmunology 5 (1), e1039763, 2016 | 104 | 2016 |
| Secretion of tumor-specific antigen by myeloma cells is required for cancer immunosurveillance by CD4+ T cells A Corthay, KU Lundin, KB Lorvik, PO Hofgaard, B Bogen Cancer research 69 (14), 5901-5907, 2009 | 57 | 2009 |
| Fingolimod blocks immunosurveillance of myeloma and B-cell lymphoma resulting in cancer development in mice KB Lorvik, B Bogen, A Corthay Blood, The Journal of the American Society of Hematology 119 (9), 2176-2177, 2012 | 45 | 2012 |
| Plasma IP-10 is increased in immunological nonresponders and associated with activated regulatory T cells and persisting low CD4 counts B Stiksrud, KB Lorvik, D Kvale, TE Mollnes, PM Ueland, M Trøseid, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 73 (2), 138-148, 2016 | 36 | 2016 |
| Activated dendritic cells and monocytes in HIV immunological nonresponders: HIV-induced interferon-inducible protein-10 correlates with low future CD4:+: recovery B Stiksrud, HCD Aass, KB Lorvik, T Ueland, M Trøseid, AM Dyrhol-Riise AIDS 33 (7), 1117-1129, 2019 | 22 | 2019 |
| Human immunodeficiency virus–infected immunological nonresponders have colon-restricted gut mucosal immune dysfunction MH Meyer-Myklestad, AW Medhus, KB Lorvik, I Seljeflot, SH Hansen, ... The Journal of infectious diseases 225 (4), 661-674, 2022 | 20 | 2022 |
| Molecular profiling of tumor-specific TH1 cells activated in vivo KB Lorvik, OAW Haabeth, T Clancy, B Bogen, A Corthay Oncoimmunology 2 (5), e24383, 2013 | 19 | 2013 |
| Is Secretion of Tumour‐specific Antigen Important for Cancer Eradication by CD4+ T Cells? – Implications for Cancer Immunotherapy by Adoptive T Cell Transfer A Corthay, KB Lorvik, B Bogen Scandinavian Journal of Immunology 73 (6), 527-530, 2011 | 14 | 2011 |
| Development of STEAP1 targeting chimeric antigen receptor for adoptive cell therapy against cancer Y Jin, KB Lorvik, Y Jin, C Beck, A Sike, I Persiconi, E Kvaløy, F Saatcioglu, ... Molecular Therapy-Oncolytics 26, 189-206, 2022 | 13 | 2022 |
| SH2D2A Modulates T Cell Mediated Protection to a B Cell Derived Tumor in Transgenic Mice T Berge, IHB Grønningsæter, KB Lorvik, G Abrahamsen, S Granum, ... PloS one 7 (10), e48239, 2012 | 9 | 2012 |
| Enhanced Gut-Homing Dynamics and Pronounced Exhaustion of Mucosal and Blood CD4+ T Cells in HIV-Infected Immunological Non-Responders KB Lorvik, MH Meyer-Myklestad, K Kushekar, C Handeland, AW Medhus, ... Frontiers in Immunology 12, 744155, 2021 | 5 | 2021 |
| Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer. Nat Commun 2011; 2: 240; PMID: 21407206 OA Haabeth, KB Lorvik, C Hammarström, IM Donaldson, G Haraldsen, ... | 5 | |
| Probiotics to HIV-infected immunological nonresponders: Altered mucosal immunity and microbial diversity restricted to ileum MH Meyer-Myklestad, AW Medhus, B Stiksrud, KB Lorvik, I Seljeflot, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 89 (1), 77-86, 2022 | 4 | 2022 |
| Activated dendritic cells and monocytes in HIV immunological non-responders; HIV-induced IP-10 correlates with low future CD4 recovery B Stiksrud, HCD Aass, KB Lorvik, T Ueland, M Trøseid, AM Dyrhol‐Riise AIDS 33 (7), 1117-1129, 2019 | 2 | 2019 |
| Adoptive Transfer of Tumor-Specific Th2 Cells Eradicates Tumors by Triggering an In Situ Inflammatory Immune... KB Lorvik, OAW Haabeth, G Haraldsen, A Corthay Cancer 76, 2016 | | 2016 |
| Cancer immunotherapy by adoptive transfer of tumor-specific Th2 cells A Corthay, C Hammarstrom, M Fauskanger, OAW Haabeth, M Zangani, ... IMMUNOLOGY 137, 706-706, 2012 | | 2012 |
| Cancer Immunosurveillance by CD4 (+) T Cells OAW Haabeth, KB Lorvik, C Hammarstrom, IM Donaldson, G Haraldsen, ... SCANDINAVIAN JOURNAL OF IMMUNOLOGY 73 (6), 603-603, 2011 | | 2011 |
